Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical trial of tropomyosin inhibitor in children with neuroblastoma in the USA.

Trial Profile

Clinical trial of tropomyosin inhibitor in children with neuroblastoma in the USA.

Planning
Phase of Trial: Phase I

Latest Information Update: 17 Nov 2017

At a glance

  • Drugs Tropomyosin inhibitors (Primary)
  • Indications Neuroblastoma
  • Focus Adverse reactions
  • Sponsors Kazia Therapeutics
  • Most Recent Events

    • 17 Nov 2017 According to a Kazia Therapeutics media release, Novogen changed its name to Kazia Therapeutics.
    • 20 May 2014 This trial is expected to start in 2015, according to a Novogen media release.
    • 20 May 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top